5月14日 - ** 制药公司Precigen PGEN.O 股价在盘前交易中飙升23.8%，至5.14美元
** 据伦敦证券交易所集团（LSEG）汇编的数据，PGEN (link) 周三晚间公布第一季度营收为2,325万美元，高于分析师平均预期的2,080万美元
** 本季度净亏损从上年同期的5,415万美元收窄至793万美元
** 截至上一交易日收盘，PGEN股价今年以来累计下跌0.7%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.